tRNA-derived fragments (tRFs) regulate post-transcriptional gene expression via AGO-dependent mechanism in IL-1β stimulated chondrocytes
Copyright © 2020 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved..
OBJECTIVES: Recent studies have shown that tRNA-derived RNA fragments (tRFs) are novel regulators of post-transcriptional gene expression. However, the expression profiles and their role in post-transcriptional gene regulation in chondrocytes is unknown. Here, we determined tRFs expression profile and explored tRF-3003a role in post-transcriptional gene regulation in IL-1β stimulated chondrocytes.
METHODS: We used qPCR arrays to determine tRNAs and tRFs expression in age- and sex-matched primary human OA chondrocytes and TC28/I2 cells stimulated with IL-1β. Chondrocytes were transfected with tRNA-CysGCA overexpression plasmid or tRF-3003a mimic and 3'UTR luciferase reporter plasmids of mRNAs harboring predicted tRF target "seed sequence". The AGO-RNA-induced silencing complex (AGO-RISC)-dependent repressive activity of tRF-3003a was determined by siRNA-mediated knockdown of AGO2.
RESULTS: IL-1β increased the expression levels of specific tRNAs and of tRF-3003a, a type 3 tRF produced by the cleavage of tRNA-CysGCA. tRF-3003a "seed sequence" was identified in the 3'UTR of JAK3 mRNA and tRNA-CysGCA overexpression or transfection of a tRF-3003a mimic in chondrocytes downregulated JAK3 expression and significantly reduced the activity of the 3'UTR reporter. RIP assay showed enrichment of tRF-3003a into AGO2/RISC in IL-1β treated chondrocytes. The suppressive effect of tRF-3003a on JAK3 3'UTR reporter was abrogated with siRNA-mediated depletion of AGO2.
CONCLUSIONS: We demonstrate that under pathological conditions chondrocytes display perturbations in the expression profile of specific tRNAs and tRFs. Furthermore, a specific tRF namely tRF-3003a can post-transcriptionally regulate JAK3 expression via AGO/RISC formation in chondrocytes. Identification of this novel mechanism may be of value in the design of precision therapies for OA.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Osteoarthritis and cartilage - 28(2020), 8 vom: 15. Aug., Seite 1102-1110 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Green, J A [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 26.07.2021 Date Revised 05.09.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.joca.2020.04.014 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM309906881 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM309906881 | ||
003 | DE-627 | ||
005 | 20231225134932.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.joca.2020.04.014 |2 doi | |
028 | 5 | 2 | |a pubmed24n1032.xml |
035 | |a (DE-627)NLM309906881 | ||
035 | |a (NLM)32407895 | ||
035 | |a (PII)S1063-4584(20)30993-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Green, J A |e verfasserin |4 aut | |
245 | 1 | 0 | |a tRNA-derived fragments (tRFs) regulate post-transcriptional gene expression via AGO-dependent mechanism in IL-1β stimulated chondrocytes |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.07.2021 | ||
500 | |a Date Revised 05.09.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved. | ||
520 | |a OBJECTIVES: Recent studies have shown that tRNA-derived RNA fragments (tRFs) are novel regulators of post-transcriptional gene expression. However, the expression profiles and their role in post-transcriptional gene regulation in chondrocytes is unknown. Here, we determined tRFs expression profile and explored tRF-3003a role in post-transcriptional gene regulation in IL-1β stimulated chondrocytes | ||
520 | |a METHODS: We used qPCR arrays to determine tRNAs and tRFs expression in age- and sex-matched primary human OA chondrocytes and TC28/I2 cells stimulated with IL-1β. Chondrocytes were transfected with tRNA-CysGCA overexpression plasmid or tRF-3003a mimic and 3'UTR luciferase reporter plasmids of mRNAs harboring predicted tRF target "seed sequence". The AGO-RNA-induced silencing complex (AGO-RISC)-dependent repressive activity of tRF-3003a was determined by siRNA-mediated knockdown of AGO2 | ||
520 | |a RESULTS: IL-1β increased the expression levels of specific tRNAs and of tRF-3003a, a type 3 tRF produced by the cleavage of tRNA-CysGCA. tRF-3003a "seed sequence" was identified in the 3'UTR of JAK3 mRNA and tRNA-CysGCA overexpression or transfection of a tRF-3003a mimic in chondrocytes downregulated JAK3 expression and significantly reduced the activity of the 3'UTR reporter. RIP assay showed enrichment of tRF-3003a into AGO2/RISC in IL-1β treated chondrocytes. The suppressive effect of tRF-3003a on JAK3 3'UTR reporter was abrogated with siRNA-mediated depletion of AGO2 | ||
520 | |a CONCLUSIONS: We demonstrate that under pathological conditions chondrocytes display perturbations in the expression profile of specific tRNAs and tRFs. Furthermore, a specific tRF namely tRF-3003a can post-transcriptionally regulate JAK3 expression via AGO/RISC formation in chondrocytes. Identification of this novel mechanism may be of value in the design of precision therapies for OA | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Chondrocyte | |
650 | 4 | |a JAK3 | |
650 | 4 | |a Noncoding RNA | |
650 | 4 | |a Osteoarthritis | |
650 | 4 | |a Transfer RNA | |
650 | 4 | |a tRNA-derived fragments | |
650 | 7 | |a 3' Untranslated Regions |2 NLM | |
650 | 7 | |a Argonaute Proteins |2 NLM | |
650 | 7 | |a Interleukin-1beta |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
650 | 7 | |a RNA, Small Untranslated |2 NLM | |
650 | 7 | |a RNA, Transfer, Cys |2 NLM | |
650 | 7 | |a RNA, Transfer |2 NLM | |
650 | 7 | |a 9014-25-9 |2 NLM | |
650 | 7 | |a JAK3 protein, human |2 NLM | |
650 | 7 | |a EC 2.7.10.2 |2 NLM | |
650 | 7 | |a Janus Kinase 3 |2 NLM | |
650 | 7 | |a EC 2.7.10.2 |2 NLM | |
700 | 1 | |a Ansari, M Y |e verfasserin |4 aut | |
700 | 1 | |a Ball, H C |e verfasserin |4 aut | |
700 | 1 | |a Haqqi, T M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Osteoarthritis and cartilage |d 1993 |g 28(2020), 8 vom: 15. Aug., Seite 1102-1110 |w (DE-627)NLM075127784 |x 1522-9653 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2020 |g number:8 |g day:15 |g month:08 |g pages:1102-1110 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.joca.2020.04.014 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2020 |e 8 |b 15 |c 08 |h 1102-1110 |